Skip to main content
Premium Trial:

Request an Annual Quote

Protagen, Dynal, Invitrogen, Brent Keller, Michael Schubert, Ian Sanders, Jean-Paul Mangeolle


New Products

Protagen has released its first two protein biochips, UNIchip AV-400 and UNIchip AV-VAR, designed for antibody validation, or use with antibody-like molecules.

The UNIchip AV-400 contains 400 predefined and purified human proteins on a nitrocellulose-coated glass side, which represent a cross section of all cellular proteins. The UNIchipAV-VAR, in contrast, contains 400 proteins which are focused on different gene ontology classes, which can be chosen by the customer.

Dynal, a subsidiary of Invitrogen, announced this week the release of its Dynabeads RPC 18. The beads offer an alternative to chromatography columns and spin columns. Based on reverse- phase chromatography or weak cation exchange, these beads can fractionate mixed protein and peptide samples quickly and easily for downstream analysis such as mass spectrometry, the company said.


Movers & Shakers

Brent Keller has been appointed general manager of Kreatech Biotechnology USA, Kreatech's new San Diego-based US office, the Amsterdam, Netherlands-based company said this week. He is currently Kreatech's vice president for commercial operations, working for the company part-time. He holds an MBA in strategic planning and marketing from Pepperdine University and a BS in biology, along with graduate training in viral immunology, from Rensselaer Polytechnic Institute.

Michael Schubert has been promoted to executive vice president and Ian Sanders to vice president for European life science sales of Bruker Daltonics, the company said last week.

Schubert retains his previous responsibilities for Bruker Daltonics' global R&D management, and remains managing director of Bruker Daltonik in Bremen and Leipzig, Germany. In addition, he now also assumes responsibility for the company's life-science mass spectrometry business in the Americas. Schubert holds a doctorate in physics from the University of Hamburg, Germany.

Sanders was previously assistant vice president. He also continues in his role as managing director of Bruker Daltonik. Schubert holds a PhD in drug discovery technology from the University of Bath, UK.

Jean-Paul Mangeolle has been promoted to president of the bioprocess division of Millipore, the company said this week. He used to be vice president of worldwide field operations for the same division. Mangeolle holds an MS in chemical engineering from the University of Montpellier in France and a BS BA in environmental engineering from the University of Chambery, France.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.